Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)
- PMID: 38249807
- PMCID: PMC10797324
- DOI: 10.3892/ol.2024.14221
Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)
Abstract
Immune checkpoint inhibitors (ICIs) are commonly utilized in tumor treatment. However, they still have limitations, including insufficient effectiveness and unavoidable adverse events. It has been demonstrated that gut microbiota can influence the effectiveness of ICIs, although the precise mechanism remains unclear. Gut microbiota plays a crucial role in the formation and development of the immune system. Gut microbiota and their associated metabolites play a regulatory role in immune balance. Tumor occurrence and development are linked to their ability to evade recognition and destruction by the immune system. The purpose of ICIs treatment is to reinitiate the immune system's elimination of tumor cells. Thus, the immune system acts as a communication bridge between gut microbiota and ICIs. Varied composition and characteristics of gut microbiota result in diverse outcomes in ICIs treatment. Certain gut microbiota-related metabolites also influence the therapeutic efficacy of ICIs to some extent. The administration of antibiotics before or during ICIs treatment can diminish treatment effectiveness. The utilization of probiotics and fecal transplantation can partially alter the outcome of ICIs treatment. The present review synthesized previous studies to examine the association between gut microbiota and ICIs, elucidated the role of gut microbiota and its associated factors in ICIs treatment, and offered direction for future research.
Keywords: fecal transplantation; gut microbiota; immune checkpoint inhibitors; immune system; immunotherapy; probiotics.
Copyright: © Jiang et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.Front Immunol. 2024 Jun 10;15:1401967. doi: 10.3389/fimmu.2024.1401967. eCollection 2024. Front Immunol. 2024. PMID: 38915399 Free PMC article. Review.
-
Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.Front Immunol. 2021 Jun 29;12:669150. doi: 10.3389/fimmu.2021.669150. eCollection 2021. Front Immunol. 2021. PMID: 34267748 Free PMC article. Review.
-
Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors.Ther Adv Med Oncol. 2023 Oct 11;15:17588359231204854. doi: 10.1177/17588359231204854. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37841750 Free PMC article. Review.
-
Microbiome bacterial influencers of host immunity and response to immunotherapy.Cell Rep Med. 2024 Apr 16;5(4):101487. doi: 10.1016/j.xcrm.2024.101487. Epub 2024 Mar 27. Cell Rep Med. 2024. PMID: 38547865 Free PMC article. Review.
-
Gut Microbiota-Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer.Cancer Manag Res. 2025 Jan 25;17:171-192. doi: 10.2147/CMAR.S405590. eCollection 2025. Cancer Manag Res. 2025. PMID: 39881948 Free PMC article. Review.
Cited by
-
The influence of the gut microbiota on B cells in autoimmune diseases.Mol Med. 2025 Apr 22;31(1):149. doi: 10.1186/s10020-025-01195-5. Mol Med. 2025. PMID: 40264032 Free PMC article. Review.
-
Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity.Cells. 2024 Aug 27;13(17):1437. doi: 10.3390/cells13171437. Cells. 2024. PMID: 39273009 Free PMC article. Review.
-
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies.Cancers (Basel). 2025 Jul 3;17(13):2228. doi: 10.3390/cancers17132228. Cancers (Basel). 2025. PMID: 40647526 Free PMC article. Review.
-
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.Vaccines (Basel). 2025 Mar 24;13(4):344. doi: 10.3390/vaccines13040344. Vaccines (Basel). 2025. PMID: 40333213 Free PMC article. Review.
-
The Impact of the Microbiota on the Immune Response Modulation in Colorectal Cancer.Biomolecules. 2025 Jul 14;15(7):1005. doi: 10.3390/biom15071005. Biomolecules. 2025. PMID: 40723882 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources